LHC Group, Inc. LHC Group, Inc.

LHC Group, Inc.

LHCG

Classifica tra le azioni #3308
LHC Group, Inc. is a healthcare organization delivering a comprehensive array... LHC Group, Inc. is a healthcare organization delivering a comprehensive array of post-acute care services, predominantly serving Medicare recipients across the United States. Its operations are organized into five distinct divisions: Home Health, Hospice, Home and Community-Based Care, Facility-Based Care, and Healthcare Innovations (HCI). The Home Health division provides skilled nursing care, social work services with a medical focus, and various rehabilitative therapies including physical, occupational, and speech therapy. Through its Hospice segment, the company delivers comprehensive end-of-life support, encompassing pain and symptom management via palliative care, emotional and spiritual guidance, inpatient and temporary respite services, homemaker assistance, nutritional advice, grief counseling for families, and social worker visits. The Home and Community-Based Services segment focuses on daily living support, offering aid with activities like personal grooming, medication reminders, meal preparation and feeding, light household chores, respite care, transportation, and running errands. The Facility-Based Services division caters to individuals with critical medical needs, demanding intensive care and continuous oversight from medical and clinical staff. Patients treated include those with respiratory failure, neurological and cardiac conditions, chronic wounds, kidney ailments, cancer, head and neck trauma, mental health disorders, and musculoskeletal issues. This segment also manages nursing facilities, a family health center, a rural health clinic, physician practices, and provides physical therapy services. Finally, the Healthcare Innovations (HCI) segment specializes in delivering strategic health management solutions to accountable care organizations. By December 31, 2021, LHC Group's operational footprint included 557 home health facilities, 170 hospice sites, 136 community-based service centers, 11 long-term acute care hospitals spread across 12 locations, and 14 Healthcare Innovations facilities. Established in 1994, the company's headquarters are situated in Lafayette, Louisiana.
Prezzo delle azioni
$169.81
Ultima sincronizzazione: 2023-02-21
Capitalizzazione di mercato
$5.26B
Variazione (1 giorno)
0.47%
Variazione (1 anno)
0.00%
Paese
US
Scambia LHC Group, Inc. (LHCG)

Categoria

Healthcare
Rapporto P/E per LHC Group, Inc. (LHCG)
Rapporto P/E al October 2026 TTM: 86.20
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di LHC Group, Inc., il rapporto P/E attuale (TTM) è 86.20. Alla fine del 2021, il rapporto P/E era 30.04.
Storico del rapporto P/E per LHC Group, Inc. da 2001 a 2026
Rapporto P/E alla fine di ogni anno
Anno Rapporto P/E Cambia
2026 (TTM) 86.20 4.76%
2022 82.28 173.94%
2021 30.04 -49.90%
2020 59.96 33.49%
2019 44.91 9.51%
2018 41.01 89.41%
2017 21.65 -1.29%
2016 21.94 -10.02%
2015 24.38 -0.90%
2014 24.60 34.09%
2013 18.35 32.38%
2012 13.86 -178.32%
2011 -17.69 -258.85%
2010 11.14 6.68%
2009 10.44 -50.94%
2008 21.28 -6.03%
2007 22.65 -4.28%
2006 23.66 -6.26%
2005 25.24 13.75%
2004 22.19 -69.47%
2003 72.69 1.30%
2002 71.76 -71.91%
2001 255.44 0.00%
Rapporto P/E per aziende simili o concorrenti
Azienda P/E Ratio Differenza del P/E Ratio Il paese
15.39 -82.14%
US
16.46 -80.91%
DE
10.40 -87.94%
US
30.12 -65.06%
SA
20.00 -76.80%
BR
Come leggere un P/E ratio?

Il rapporto Prezzo/Utile (P/E) misura la relazione tra il prezzo delle azioni di una società e i suoi utili per azione.
Un P/E basso ma positivo indica un'azienda che genera alti profitti rispetto alla sua valutazione attuale e potrebbe essere sottovalutata. Un'azienda con un P/E negativo elevato (vicino allo 0) segnala forti perdite rispetto alla valutazione.

Le aziende con un P/E superiore a 30 o negativo sono generalmente considerate "azioni di crescita", cioè ci si aspetta che crescano o diventino redditizie.

Le aziende con un P/E positivo inferiore a 10 sono considerate "azioni di valore", ossia già molto redditizie ma con scarse prospettive di crescita.